Simon Cauchemez - Curriculum Vitae#

• 2002 - 2005 PhD in Biostatistics, Université Pierre et Marie Curie, Paris, France
  
• 2001 - 2002 Master in Biomathematics, Université Pierre et Marie Curie, Paris, France
  
• 1998 - 2001 ENSAE in statistics / economics, Malakoff, France. ENSAE is the National School for Statistics and Economic Administration

• 2024 - now Member of the Scientific Advisory Board (SAB) of CARE, Center for African Resilience for Epidemics, Senegal
  
• 2023 - now Member of the SAB of the MRC Center for Global Infectious Diseases Analysis, Imperial College London, UK
  
• 2022 - now Member of COVARS, French committee for monitoring and anticipating health Risks
  
• 2022 - now Member of the SAB of OptimAgent modelling project, Germany
  
• 2022 - now Member of the SAB of the National Institute for Health Research (NIHR) Health Protection Research Unit (HPRU) in Modelling and Health Economics, UK
  
• 2022 - now Member of the SAB of Domaine d’Intérêt Majeur (DIM) One Health, Région Ile de France
  
• 2021 - now Co-President of the Coordinated Action in charge of coordinating French research on infectious disease modelling at ANRS-MIE
  
• 2021 - now Member of the Board of Reviewing Editors of the journal Science
  
• 2021 - now Co-director of the 1-week course Modelling of Infectious Diseases, Institut Pasteur
  
• 2020 - 2022 Member of the COVID19 Scientific Council of the Ministry of Health, France
  
• 2020 - 2024 Member of the Population and Public Health Expert Review Group, Wellcome Trust
  
• 2019 - 2021 Member of the steering committee of US NIGMS Models of Infectious Disease Agent Study (MIDAS)
  
• 2018 - 2021 Member of COMESP, the committee in charge of evaluating scientists at Institut Pasteur. President of subcommittee about modelling, biostatistics and bioinformatics
  
• 2017 - now Member of the Scientific Advisory Board of Institut Pasteur Madagascar
  
• 2017 - 2020 Member of the Scientific Advisory Board of Institut Pasteur Cambodia

• 2025 Labex IBEID, “Analysis and modelling of infectious diseases epidemics to support evidence based policy making in France”, PI, 60k €.
  
• 2024 - 2031 Wellcome Trust, Risk Assessment Community Spread Multiple Endemic Infectious Pathogens (RACSMEI), co-Investigator, 400k €.
  
• 2024 - 2026 HAS, Modelling of vaccination strategies for HAS recommendations, PI, up to 200k €.
  
• 2024 - 2025 EU LEAPS, Integrating Multi-Disciplinary Expertise in a Learning and Adaptive European Pandemic Preparedness System, Co-investigator, 110k €.
  
• 2023 - 2027 EU DURABLE, Delivering a Unified Research Alliance of Biomedical and public health Laboratories against Epidemics, Workpackage leader, 515k €.
  
• 2023 - 2025 AXARF, Influenza virus antibody landscapes to decipher the drivers of influenza epidemics, PI, 291k €.
  
• 2022 - 2024 ANRS-MIE, MPX-SPREAD, Characterizing the spreading dynamics of 2022 monkeypox outbreak in France to aid public health policies, Co-Investigator, 34k €.
  
• 2021 - 2025 NIH, PICREID Inter-regional study of transmission, adaptation and pathogenesis of viruses with pandemic potential in Southeast Asia and West/Central Africa, Co-investigator, 220k $.
  
• 2020 - 2025 EU H2020 VEO, Versatile Emerging infectious disease Observatory, Co-investigator, 198k €.